SCHEMBL7955166

SCHEMBL7955166

[CH2]c1cc(OC)c(OC)c(OCCCN(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 1/20 0.47
SCN1A P35498 1/20 0.43
SCN2A Q99250 1/20 0.43
SCN3A Q9NY46 1/20 0.43
CYP2C19 P33261 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
AOC3 Q16853 1/20 0.41
HTR7 P34969 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
HTR1B P28222 1/20 0.40
LMNA P02545 1/20 0.39
DRD2 P14416 1/20 0.39
ACHE P22303 1/20 0.39
SLC6A2 P23975 1/20 0.39
DRD3 P35462 1/20 0.39
KCNH2 Q12809 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8188932 0.92 HTR7 (0.49) FYNSCN1ASCN2ASCN3ACYP2C19
SCHEMBL4036416 0.84 FYN (0.53) FYNSCN1ASCN2ASCN3ACYP2C19
SCHEMBL7945829 0.80 FDPS (0.49) FYNSCN1ASCN2ASCN3ALMNA
SCHEMBL58988 0.76 ACHE (0.59) CYP1A2ACHEALDH1A1PTGS2
SCHEMBL5241628 0.75 PTGS2 (0.50) CYP2C19CYP1A2CYP2D6ACHEALDH1A1
SCHEMBL4045745 0.75 HTR7 (0.49) FYNCYP2C19AOC3HTR7LMNA
SCHEMBL27736458 0.74 ACHE (0.56) CYP1A2ACHEALDH1A1PTGS2
SCHEMBL11774217 0.73 KDM4E (0.50) CYP2C19CYP1A2CYP2D6HRH3LMNA
SCHEMBL7959809 0.73 SPIN1 (0.57) SCN1ASCN2ASCN3ACYP2C19CYP1A2
SCHEMBL9306683 0.73 AOC3 (0.64) AOC3PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297274-B1 SUBSTITUTED 5-HYDROXYFURANONES WARNER-LAMBERT COMPANY 2001-10-02 US claimed
US-5922759-A Butenolide endothelin antagonists WARNER-LAMBERT COMPANY (US) 1999-07-13 US claimed
WO-1997037985-A1 NONPEPTIDE ENDOTHELIN ANTAGONISTS WITH INCREASED WATER SOLUBILITY WARNER-LAMBERT COMPANY (US) 1997-10-16 WO claimed
US-6297274-B1 SUBSTITUTED 5-HYDROXYFURANONES WARNER-LAMBERT COMPANY 2001-10-02 US disclosed
US-6017951-A TREATING RENAL FAILURE, HYPERTENSION, MYOCARDIAL INFARCTION AND MYOCARDIAL ISCHEMIA, CEREBRAL VASOSPASM, CIRRHOSIS, SEPTIC SHOCK, CONGESTIVE HEART FAILURE, ENDOTOXIC SHOCK, SUBARACHNOID HEMORRHAGE, ARRHYTHMIAS, ASTHMA, ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 2000-01-25 US disclosed
US-5922759-A Butenolide endothelin antagonists WARNER-LAMBERT COMPANY (US) 1999-07-13 US disclosed
WO-1997037985-A1 NONPEPTIDE ENDOTHELIN ANTAGONISTS WITH INCREASED WATER SOLUBILITY WARNER-LAMBERT COMPANY (US) 1997-10-16 WO disclosed
WO-1997002265-A1 BUTENOLIDE ENDOTHELIN ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-01-23 WO disclosed